These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [A new therapeutic possibility for type 2 diabetes: DPP-4 inhibitors (sitagliptin)].
    Author: Abel T, Fehér J.
    Journal: Orv Hetil; 2010 Jun 20; 151(25):1012-6. PubMed ID: 20519186.
    Abstract:
    Type 2 diabetes is a very common worldwide disorder. A good glycemic control is reduce the rates of diabetes associated microvascular and possibly macrovascular complications. Dipeptidyl peptidase-4 (DPP-4) inhibitors such as sitagliptin demonstrate an incretin based, glucose-dependent actions with low risk of hypoglycemia and no weight gain during the treatment of patients with type 2 diabetes.
    [Abstract] [Full Text] [Related] [New Search]